Potassium channels in myotonic dystrophy type 1
1 型强直性肌营养不良中的钾通道
基本信息
- 批准号:7978133
- 负责人:
- 金额:$ 7.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultBindingCell membraneCellsChildCytoplasmDataDifferentiation AntigensDoseGLUT4 geneGelatinase AGlucoseGlucose TransporterGoalsHumanImpairmentInheritedInsulinInsulin ReceptorInsulin ResistanceMatrix MetalloproteinasesMeasuresMental RetardationMusMuscleMuscle CellsMuscle DevelopmentMuscle FibersMyoblastsMyopathyMyotonic DystrophyNeuromuscular DiseasesNon-Insulin-Dependent Diabetes MellitusPhosphorylationPhosphorylation InhibitionPhosphotransferasesPhysiologicalPlayPotassium ChannelPotassium Channel BlockersProductionProtein BiosynthesisProteinsPublic HealthRegulationRoleSignal Transductionbasechannel blockersdesignglucose uptakeimprovedinsulin sensitivitymuscle formmyogenesisnew therapeutic targetolfactory bulbpublic health relevancereceptorresponsewasting
项目摘要
DESCRIPTION (provided by applicant): Myotonic dystrophy type 1 (DM1) is the most common inherited neuromuscular disorder in adults. It is characterized by progressive muscle wasting and weakness in adults. In addition to these features, DM1 is often associated with insulin resistance, leading to type-2 diabetes. Children with congenital DM1, the most severe form of DM1, present with muscle underdevelopment and mental retardation. A strategy designed to increase insulin sensitivity, and therefore glucose uptake, by muscular cells while improving the differentiation of myoblasts into functional myotubes would improve muscle mass and function in children with congenital DM1, and also possibly in adults with DM1. Human myoblasts, the precursors of muscle cells, express different subsets of potassium channels, including Kv1.3 and Kv1.5 channels. We have found that a blocker of both Kv1.3 and Kv1.5 channels improved GLUT4 translocation to the plasma membrane of human DM1 myoblasts in response to insulin. Blocking Kv1.3 channels also increased production of matrix metalloproteinase-2 (MMP-2) in DM1 myoblasts where it is significantly lower than in normal myoblasts. Our data suggest that blocking Kv1 channels in DM1 myoblats has the potential of improving insulin sensitivity and myoblasts fusion and differentiation. Based on these exciting results, we plan on examining if Kv1 channel blockers improve glucose uptake in DM1 myoblasts. We will also examine the effect of these blockers on the efficiency of protein synthesis and on the formation of myotubes. Under Aim 1 we will determine the effects of blocking Kv1 channels on glucose uptake and protein synthesis by DM1 myoblasts and assess whether kinases involved in glucose uptake are activated in DM1 myoblasts. Under aim 2 we will determine the effects of blocking Kv1 channels on the production of different MMPs and on the differentiation of myoblasts in to myotubes. Potassium channels may represent new targets for the treatment of insulin resistance, muscle underdevelopment, and muscle wasting in children with congenital DM1, and possibly in adults with DM1 and other dystrophies.
PUBLIC HEALTH RELEVANCE: Public Health Relevance Myotonic dystrophy type 1 is the most common inherited neuromuscular disorder in adults. Our goal is to develop a strategy for treating two major aspects of this disease - muscle underdevelopment and wasting, and insulin resistance - by targeting potassium channels on myoblasts. Such new therapeutic targets would have tremendous benefits for public health.
描述(申请人提供):强直性肌营养不良1型(DM1)是成人最常见的遗传性神经肌肉疾病。它的特点是成年人进行性肌肉萎缩和虚弱。除了这些特征外,DM1还经常与胰岛素抵抗有关,从而导致2型糖尿病。患有先天性DM1的儿童是DM1最严重的形式,表现为肌肉发育不全和智力低下。一种旨在增加肌肉细胞对胰岛素的敏感性,从而增加肌肉细胞对葡萄糖的摄取,同时促进成肌细胞分化为功能性肌管的策略,将改善先天性DM1儿童的肌肉质量和功能,也可能改善患有DM1的成年人的肌肉质量和功能。人成肌细胞是肌细胞的前体,表达不同的钾通道亚群,包括Kv1.3和Kv1.5通道。我们发现Kv1.3和Kv1.5通道的阻断剂改善了胰岛素对人DM1成肌细胞质膜的GLUT4易位。阻断Kv1.3通道也增加了DM1成肌细胞中基质金属蛋白酶-2(MMP-2)的产量,而在正常成肌细胞中,基质金属蛋白酶-2的产量显著低于正常成肌细胞。我们的数据表明,阻断DM1成肌细胞中的KV1通道具有改善胰岛素敏感性和成肌细胞融合和分化的潜力。基于这些令人兴奋的结果,我们计划研究KV1通道阻滞剂是否能改善DM1成肌细胞对葡萄糖的摄取。我们还将研究这些阻滞剂对蛋白质合成效率和肌管形成的影响。在目标1下,我们将确定阻断KV1通道对DM1成肌细胞葡萄糖摄取和蛋白质合成的影响,并评估参与葡萄糖摄取的激酶在DM1成肌细胞中是否被激活。在目标2下,我们将确定阻断KV1通道对不同MMPs的产生和成肌细胞向肌管分化的影响。钾通道可能是治疗胰岛素抵抗、肌肉发育不良和先天性DM1儿童肌肉萎缩的新靶点,可能也适用于患有DM1和其他营养不良的成年人。
公共卫生相关性:强直性肌营养不良1型是成人最常见的遗传性神经肌肉疾病。我们的目标是开发一种策略,通过靶向成肌细胞的钾通道来治疗这种疾病的两个主要方面-肌肉发育不足和萎缩,以及胰岛素抵抗。这些新的治疗目标将对公众健康产生巨大的好处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine Beeton其他文献
Christine Beeton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine Beeton', 18)}}的其他基金
New Peptides for the Treatment of Multiple Sclerosis
治疗多发性硬化症的新肽
- 批准号:
8473290 - 财政年份:2011
- 资助金额:
$ 7.68万 - 项目类别:
New Peptides for the Treatment of Multiple Sclerosis
治疗多发性硬化症的新肽
- 批准号:
8325540 - 财政年份:2011
- 资助金额:
$ 7.68万 - 项目类别:
New Peptides for the Treatment of Multiple Sclerosis
治疗多发性硬化症的新肽
- 批准号:
8660717 - 财政年份:2011
- 资助金额:
$ 7.68万 - 项目类别:
New Peptides for the Treatment of Multiple Sclerosis
治疗多发性硬化症的新肽
- 批准号:
8236305 - 财政年份:2011
- 资助金额:
$ 7.68万 - 项目类别:
Potassium channels in myotonic dystrophy type 1
1 型强直性肌营养不良中的钾通道
- 批准号:
8288654 - 财政年份:2010
- 资助金额:
$ 7.68万 - 项目类别:
Targeting T lymphocyte potassium channels for the treatment of asthma--OLD
靶向T淋巴细胞钾通道治疗哮喘--OLD
- 批准号:
8122828 - 财政年份:2010
- 资助金额:
$ 7.68万 - 项目类别:
Potassium channels in myotonic dystrophy type 1
1 型强直性肌营养不良中的钾通道
- 批准号:
8101904 - 财政年份:2010
- 资助金额:
$ 7.68万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
The development of artificial cell membrane binding proteins
人工细胞膜结合蛋白的开发
- 批准号:
133361 - 财政年份:2018
- 资助金额:
$ 7.68万 - 项目类别:
Feasibility Studies
Establish the new method for making antibody binding to cell membrane receptor in T cell lymphoma
建立T细胞淋巴瘤抗体与细胞膜受体结合的新方法
- 批准号:
16K09838 - 财政年份:2016
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interaction Between Lantibiotics and Liposomes: Mimicking Binding to the Cell Membrane
羊毛硫抗生素和脂质体之间的相互作用:模拟与细胞膜的结合
- 批准号:
425498-2012 - 财政年份:2012
- 资助金额:
$ 7.68万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
CAREER: Development of Novel Methods to Measure Cell Membrane Protein Clustering in vivo: Unraveling the Relationship between Clustering, Ligand Binding and Cell Signaling
职业:开发体内测量细胞膜蛋白聚类的新方法:揭示聚类、配体结合和细胞信号传导之间的关系
- 批准号:
0845236 - 财政年份:2009
- 资助金额:
$ 7.68万 - 项目类别:
Standard Grant
Spatial Monte Carlo models for VEGF binding on the cell membrane
VEGF 与细胞膜结合的空间蒙特卡罗模型
- 批准号:
7532889 - 财政年份:2008
- 资助金额:
$ 7.68万 - 项目类别:
Spatial Monte Carlo models for VEGF binding on the cell membrane
VEGF 与细胞膜结合的空间蒙特卡罗模型
- 批准号:
8109900 - 财政年份:2008
- 资助金额:
$ 7.68万 - 项目类别:
Spatial Monte Carlo models for VEGF binding on the cell membrane
VEGF 与细胞膜结合的空间蒙特卡罗模型
- 批准号:
7689413 - 财政年份:2008
- 资助金额:
$ 7.68万 - 项目类别:
Spatial Monte Carlo models for VEGF binding on the cell membrane
VEGF 与细胞膜结合的空间蒙特卡罗模型
- 批准号:
8304298 - 财政年份:2008
- 资助金额:
$ 7.68万 - 项目类别:
The mechanism of the Action of the calcium-binding protein ALG-2on the regulation of cell membrane receptor sorting
钙结合蛋白ALG-2调控细胞膜受体分选的作用机制
- 批准号:
17380063 - 财政年份:2005
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Ultrastructural Analysis of Mechanism of Protein-Domain-Assembly on Cell Membrane of Specific Lipid-Binding Toxin.
特定脂质结合毒素细胞膜上蛋白质结构域组装机制的超微结构分析。
- 批准号:
15590396 - 财政年份:2003
- 资助金额:
$ 7.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)